These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24399653)

  • 1. [Do inhaled corticosteroids favor pneumonia in COPD? Particularly fluticasone increases the risk of pneumonia].
    Worth H
    Dtsch Med Wochenschr; 2014 Jan; 139(3):76. PubMed ID: 24399653
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated review.
    Iannella H; Luna C; Waterer G
    Ther Adv Respir Dis; 2016 Jun; 10(3):235-55. PubMed ID: 26893311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.
    Dransfield MT; Bourbeau J; Jones PW; Hanania NA; Mahler DA; Vestbo J; Wachtel A; Martinez FJ; Barnhart F; Sanford L; Lettis S; Crim C; Calverley PM
    Lancet Respir Med; 2013 May; 1(3):210-23. PubMed ID: 24429127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice.
    Vestbo J; Leather D; Diar Bakerly N; New J; Gibson JM; McCorkindale S; Collier S; Crawford J; Frith L; Harvey C; Svedsater H; Woodcock A;
    N Engl J Med; 2016 Sep; 375(13):1253-60. PubMed ID: 27593504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal of inhaled glucocorticoids and exacerbations of COPD.
    Magnussen H; Disse B; Rodriguez-Roisin R; Kirsten A; Watz H; Tetzlaff K; Towse L; Finnigan H; Dahl R; Decramer M; Chanez P; Wouters EF; Calverley PM;
    N Engl J Med; 2014 Oct; 371(14):1285-94. PubMed ID: 25196117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide and risk of pneumonia.
    Singanayagam A; Chalmers JD
    Lancet; 2009 Dec; 374(9707):2050. PubMed ID: 20109824
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhaled fluticasone and budesonide increased the risk of serious pneumonia in COPD.
    White P
    Evid Based Med; 2014 Jun; 19(3):116. PubMed ID: 24530996
    [No Abstract]   [Full Text] [Related]  

  • 8. Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials.
    Halpin DM; Gray J; Edwards SJ; Morais J; Singh D
    Int J Clin Pract; 2011 Jul; 65(7):764-74. PubMed ID: 21676119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
    Larsson K; Janson C; Lisspers K; Jørgensen L; Stratelis G; Telg G; Ställberg B; Johansson G
    J Intern Med; 2013 Jun; 273(6):584-94. PubMed ID: 23495860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
    Latorre M; Novelli F; Vagaggini B; Braido F; Papi A; Sanduzzi A; Santus P; Scichilone N; Paggiaro P
    Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial.
    Crim C; Calverley PMA; Anderson JA; Holmes AP; Kilbride S; Martinez FJ; Brook RD; Newby DE; Yates JC; Celli BR; Vestbo J;
    Respir Med; 2017 Oct; 131():27-34. PubMed ID: 28947039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD.
    Crim C; Dransfield MT; Bourbeau J; Jones PW; Hanania NA; Mahler DA; Vestbo J; Wachtel A; Martinez FJ; Barnhart F; Lettis S; Calverley PM
    Ann Am Thorac Soc; 2015 Jan; 12(1):27-34. PubMed ID: 25490706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study.
    Man SF; Xuekui Zhang ; Vessey R; Walker T; Lee K; Park D; Sin DD
    Ther Adv Respir Dis; 2009 Apr; 3(2):73-80. PubMed ID: 19465442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk and outcomes of pneumonia in patients on inhaled corticosteroids.
    Sibila O; Soto-Gomez N; Restrepo MI
    Pulm Pharmacol Ther; 2015 Jun; 32():130-6. PubMed ID: 25956073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies.
    Loke YK; Cavallazzi R; Singh S
    Thorax; 2011 Aug; 66(8):699-708. PubMed ID: 21602540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of inhaled salmeterol, alone and in combination with fluticasone propionate, on management of COPD patients.
    Mansori F; Nemat Khorasani A; Boskabady MH; Boskabady M
    Clin Respir J; 2010 Oct; 4(4):241-7. PubMed ID: 20887348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroids in COPD and the risk of serious pneumonia.
    Suissa S; Patenaude V; Lapi F; Ernst P
    Thorax; 2013 Nov; 68(11):1029-36. PubMed ID: 24130228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
    Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID
    Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.
    Ernst P; Gonzalez AV; Brassard P; Suissa S
    Am J Respir Crit Care Med; 2007 Jul; 176(2):162-6. PubMed ID: 17400730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD).
    Med Lett Drugs Ther; 2010 May; 52(1339):41-2. PubMed ID: 20508579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.